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 Abstract.  The impact of a sustained release metofluthrin emanator and an allethrin-based mosquito coil on biting, 
movement and mortality of female  Aedes aegypti was assessed in an apartment. In the room in which the metofluthrin 
emanator was activated, mosquito biting counts were reduced to zero. Metofluthrin also had a spillover effect, signifi-
cantly ( P < 0.001) reducing biting counts in a neighboring room 1, 4, and 24 hours after the emanator was activated when 
compared with either the coil or control (untreated) treatment. Mosquitoes were neither repelled nor expelled from a 
room exposed to metofluthrin. Indeed, a significantly ( P = 0.023) greater proportion of mosquitoes were found in the 
treated room after exposure to metofluthrin when compared with either the coil or control treatment. Furthermore, in the 
room treated with metofluthrin the majority of mosquitoes died and a spillover effect into the neighboring room caused 
greater than one-third mortality of the mosquitoes. Metofluthrin could be used to prevent dengue transmission within a 
household. 
 INTRODUCTION 
 In northeastern Australia and throughout the tropical 
regions of the world the yellow fever mosquito,  Aedes aegypti 
(L.) is a primary vector of dengue viruses. 1,2 This day-biting 
mosquito has a close association with the urban environment, 3,4 
almost exclusively feeding on human hosts 5,6 and breeding in 
artificial containers found in the domestic setting (i.e., pot 
plant bases, tires, roof gutters, etc.). 7  Aedes aegypti regularly 
take multiple blood meals, often from different humans, to 
complete their gonotrophic cycle. 6 Multiple blood feeding is 
epidemiologically important because it increases the probabil-
ity of a mosquito contracting or transmitting a virus infection, 
often leading to clusters of dengue virus infections to occur in 
time and space (i.e., family and neighboring units). 5 
 It is therefore imperative that during a dengue outbreak 
people infected with the virus and their closest neighbors take 
precautions to prevent vectors biting to interrupt the virus 
transmission cycle. Traditionally, mosquito coils and insecti-
cidal vaporizing mats or liquids have been used to deter mos-
quitoes from biting, but these products are limited in their use 
by the requirement for a heat or power source to vaporize 
their active ingredient, commonly a synthetic pyrethroid such 
as d-allethrin or prallethrin. 8–10 Furthermore, burning mos-
quito coils release significant amounts of fine particulate mat-
ter and volatile organic compounds that may pose an acute 
and chronic risk to human health. 11 
 However, studies into the insecticidal activity of norchry-
santhemic acid esters with high vapor activity at ambient 
temperature by Ujiahra and others 12 identified a synthetic 
pyrethroid insecticide (“metofluthrin”) that doesn’t require 
a heating source and was extremely effective at knocking 
down  Culex pipiens pallens in the laboratory. Metofluthrin has 
also been shown, with aspirator collections, to provide spatial 
repellency to mosquitoes in outdoor shelters without walls 13,14 
and in houses. 15–17 Furthermore, metofluthrin has significantly 
reduced landing rates of  Aedes species, 8,9 and reduced the 
number of  Aedes albopictus caught in Centers for Disease 
Control and Prevention (CDC)-type miniature mosquito 
traps, 18 in field trials. However, these studies failed to eluci-
date mosquito movement associated with metofluthrin expo-
sure or the fate of mosquitoes after exposure. To achieve this 
we exposed marked cohorts of female  Ae. aegypti mosquitoes 
to metofluthrin in an indoor domestic environment to mea-
sure the effects of its impact on 1) mosquito-human biting, 
2) mosquito repulsion/expulsion, and 3) mosquito mortality. 
 MATERIALS AND METHODS 
 Experimental rooms.  Our research was conducted in a two 
bedroom apartment in Cairns, Queensland, Australia in June 
and July 2007. The two adjacent rooms used for the experiment 
were of similar size (Room 1: 3.8 × 2.6 × 2.45 m = 24.2 m 3 ; 
Room 2: 3.8 × 2.75 × 2.45 m = 25.6 m 3 ) and were connected 
by a 2.0 × 0.8 m door. Mosquitoes were contained within the 
experimental rooms by sealing doorways to the adjoining 
living room and bathroom with white cotton curtain using duct 
tape. A zipper in the living room curtain allowed us to enter 
the treatment rooms. The door between the bedrooms was 
left open to allow mosquitoes free access to both rooms. The 
floor of each experimental room was covered with white drop 
sheets to facilitate collection of dead mosquitoes at the end of 
each treatment replicate (after 24 hours). Each experimental 
room had a wardrobe containing clothing and was furnished 
with a black suitcase, green box, black laundry hamper, black 
pot, and a cardboard box that could be used by mosquitoes for 
harborage ( Figure 1 ). Windows in each room were left open but 
were screened to prevent mosquito escape, and an overhead 
fan set on “low” to provide ventilation. By using insecticidal 
treatments in only one room at a time, and by releasing a 
uniquely marked cohort of mosquitoes in each room, we could 
determine if mosquitoes traveled freely between rooms, and 
the mortality of each cohort in each room. 
 Treatments and replication.  The metofluthrin emanator was 
a 20 × 15 × 10 cm lightweight and portable concertina tower 
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of metofluthrin-impregnated paper (containing 26 mg AI) 
(Reckitt Benckiser Pty. Ltd., West Ryde, New South Wales 
Australia) that passively dispensed metofluthrin for ~80 hours 
at 28°C (Graeme Smith, Reckitt Benckiser Pty Ltd., unpub-
lished data). The small, lightweight towers are portable and 
easily moved to provide personal protection from mosquitoes 
biting. The effect the metofluthrin-impregnated tower had on 
 Ae. aegypti biting, movement, and mortality in a room was 
compared with that elicited by a standard Mortein coil (0.2% 
d-allethrin; Reckitt Benckiser Pty. Ltd.) in the room, and a 
control (with neither tower nor coil in the room). Uniquely 
marked cohorts of 20 female  Ae. aegypti were exposed to 
each pesticide treatment within the treatment room while the 
adjacent room was untreated. One replicate of each treatment 
was conducted in succession (i.e., metofluthrin, coil, and then 
control) and the order in which they were performed was 
randomized; there were six replicates in total. To minimize 
room effect on mosquito behavior, the treated room was 
alternated with the neighboring room after three replicates. 
New metofluthrin strips and coils were used for each trial 
and run for 24 hours, although the coil only had a lifespan of 
8 hours. After each metofluthrin and coil trial, the apartment 
was aired out for 48 and 24 hours, respectively, to dissipate 
residual pyrethroid insecticide. 
 Mosquito rearing, sexing, and dusting.  Mosquitoes used 
were laboratory reared, third generation  Ae. aegypti originally 
collected from Parramatta Park, a suburb of Cairns. These 
mosquitoes were reared in a partially controlled temperature 
(range 20–29°C) environment. Eggs were hatched in hay 
infusion and larvae were reared in metal trays on a cat food 
(Purina Friskies dry adult cat food, Nestle Purina Petcare, 
North Ryde, New South Wales, Australia ) diet until pupation. 
Adult  Ae. aegypti were kept in 35 × 25 × 15-cm plastic cages 
and offered a 5–10% honey solution. To sort mosquitoes, the 
cage was placed in a 5°C cool room for 5 minutes to stupefy 
the mosquitoes. Females were then removed using a mouth 
aspirator and cohorts of 20, 4–11-day-old, non-bloodfed female 
 Ae. aegypti were placed into 1-L plastic holding containers. 
These containers were then held at room temperature until 
mosquitoes became active (~30 minutes) at which time they 
were dusted with Radglo fluoro paint using an insufflator. 19 
Two sets of two colors were used to mark treatment and 
control cohorts (set one: blue and magenta; set two: yellow 
and orange), and were alternated with each experimental 
replicate. The mosquitoes were then held unfed in the cage 
overnight (~12 hours) at 25°C until release the next day. 
 Mosquito release and apartment setup.  Mosquitoes were 
transported to the apartment in an insulated cooler, and 
the holding cage was exposed to ambient conditions in the 
apartment for 10 minutes before being released. Specific-
colored mosquitoes (20) were released at 10:40  am into the 
center of each room with the door between the two rooms left 
closed ( Table 1 ). Temperature and relative humidity within the 
apartment were recorded in one room using a TinyTag Gemini 
Data Logger (Chichester, West Sussex, UK) . 
 Assessment of mosquito biting, movement, and mortality. 
 The experimental rooms were left vacant for 20 minutes 
after mosquito release. A human landing count (performed 
while sitting) was then conducted to assess biting rates 
before initiating treatments. The count involved recording all 
mosquito landings on the lower right leg (exposed area was 
knee to toe) in which probing was initiated, before a hand was 
used to flush mosquitoes off the leg, over a 10-minute period. 
Landing counts were conducted by the same human subject 
for the entire experiment. The metofluthrin or coil, placed on 
a 0.4 m high box located 1.2 from the chair used for the biting 
assessments, was then activated. The door between the treated 
and neighboring room was then opened. Additional biting ass-
essments were undertaken 1, 4, and 24 hours post-treatment 
at the same time each day to account for periodicity effects 
in mosquito behavior ( Table 1 ). During biting assessments, 
the bedroom door was closed to prevent mosquitoes moving 
between rooms. 
 Mosquito movement and mortality was assessed at the com-
pletion of each treatment replicate by tallying both alive and 
dead mosquitoes in each room, and identifying from which 
room the mosquitoes were released by recording their marked 
color when placed under an ultraviolet light. To determine the 
influences of mosquito harborage sites, the location of dead 
mosquitoes was also recorded in relation to each item placed 
in the rooms for mosquito harborage. 
 Data analyses.  Mosquito biting data, obtained through 
human landing counts of female  Ae. aegypti , were square 
root (X + 0.5) transformed to normality. A one-way analysis 
of variance (ANOVA) and type III error was then used to 
test for treatment effects at each of the count periods (pre-
treatment and 1, 4, and 24 hours after the application of the 
treatment) for both the treated and untreated rooms. To 
identify significantly different treatments, the least significant 
difference (LSD) post-hoc test was applied. At the end of 
 Figure 1.  Experimental room with a chair used for mosquito bit-
ing assessments (center) and mosquito harborage sites (cardboard 
box is not in figure). 
 Table 1 
 Schedule for assessing mosquito behavior for all treatments 
Time of day Activity
10:40  am Mosquitoes released
11:00  am Pre-treatment landing count
11:30  am Treatment added to one room
12:30  pm 1 hour landing count
 3:30  pm 4 hour landing count
11:30  am 24 hour landing count
12:00 noon Collection and assessment of 
movement and mortality
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the 24-hour exposure period an assessment of mosquito 
movement was undertaken by determining the proportion of 
each mosquito cohort present in each room. The proportion of 
mosquitoes that had remained, exited, or were lost in relation 
to the room in which they were released (treated or untreated) 
was also determined. The proportion of dead mosquitoes 
in each room was determined for each cohort. Proportional 
data were arcsine square-root transformed then analyzed by 
ANOVA and LSD post-hoc test. All analyses were performed 
in SPSS (version 14.0, SPSS Inc., Chicago, IL). 
 RESULTS 
 Temperature and relative humidity.  June temperatures 
(mean minimum = 22.7; mean maximum = 23.8°C) and 
relative humidity (mean minimum = 68.1%; mean maximum = 
80.4%) were higher than the temperatures (mean minimum = 
18.8; mean maximum = 22.7°C) and relative humidity (mean 
minimum = 51.5%; mean maximum = 66.6%) recorded 
throughout July. 
 Mosquito biting: treated room.  The pretreatment 10 minutes 
landing rate was positively correlated with temperature in the 
treated ( r = 0.80) and untreated ( r = 0.81) rooms. Metofluthrin 
was extremely effective at preventing biting in the treated 
room, reducing landing counts to zero for all metofluthrin 
treatments during assessments made at 1, 4, and 24 hours 
post-treatment ( Figure 2 ). Similar results, although not 100% 
biting inhibition was recorded with the coil at the 1 and 4 hour 
assessments. However, at the 24 hour assessment the landing 
count was not significantly different ( Table 2 ) from the control 
( Figure 2 ). We suspect that the increase in landing rates was 
from mosquitoes that had recovered after the coil burned out 
after 8 hours. 
 Mosquito biting: neighboring (untreated) room.  The three 
treatments had a significantly different impact on  Ae. aegypti 
landing rates in the neighboring room ( Table 2 ). Although 
human landing counts were not reduced to absolute zero in 
the neighboring room, the spillover effect of metofluthrin 
resulted in significantly ( Table 2 ) fewer landings than with the 
control at 1, 4, and 24 hour post-treatment ( Figure 2 ). The coil 
only resulted in a significant reduction in landing counts at the 
4 hour assessment ( Table 2 ), albeit less than that recorded for 
metofluthrin ( Figure 2 ). 
 Mosquito movement.  The majority of mosquitoes released in 
the treated and untreated rooms moved readily between rooms 
for all treatments, and only a small percentage of mosquitoes 
was not recovered (“lost”) ( Figure 3 ). A significantly ( F = 4.88, 
 P = 0.023) higher proportion of mosquitoes were found in the 
treated room after the metofluthrin treatment than with either 
the coil or control treatments ( Figure 4 ). This was a result of 
the knockdown of a greater number of mosquitoes entering 
the treatment room from the neighboring room compared 
with either the coil (LSD,  P = 0.006) or control treatment 
(LSD,  P = 0.088). Indeed, after 24 hours 58.3% of mosquitoes 
released into the neighboring room had exited that room 
and were found in the room in which the metofluthrin tower 
had been activated, compared with 27.5% and 40.8% for the 
coil and control treatments, respectively ( Figure 5 ). There 
was no significant difference ( F = 2.02,  P = 0.167) between 
treatments for the number of mosquitoes leaving the treated 
room ( Figure 5 ). 
 Mosquito mortality.  Mortality was very low for the control 
and coil treatments, but much higher for both cohorts in 
the metofluthrin treatment ( Figure 3 ). At the household 
level (i.e., mortality pooled from both rooms) it resulted in a 
significantly ( F = 112.73,  P < 0.001) greater proportion of dead 
mosquitoes, compared with either the coil or control ( Figure 6 ). 
Mosquito collections after 24 hours revealed that 98% of 
mosquitoes collected in the room in which the metofluthrin 
tower was activated were dead. This was significantly ( F = 174.01, 
 P < 0.001) higher mortality compared with negligible deaths 
for the other two treatments. Similar to the landing count results, 
metofluthrin had a spillover effect into the neighboring room 
causing significantly ( F = 16.96,  P < 0.001) higher mortality 
(> ⅓ of mosquitoes collected) compared with the coil and 
control treatments. In the treated room (131, 85%) dead 
mosquitoes were found associated (on or very close to) with 
harborage areas (suitcase, hamper, wardrobe, etc.) with only 
12 and 10, respectively, found at the window and door. In the 
 Table 2 
 Statistical results (one-way ANOVA and post hoc LSD) for mosquito landing counts for both the treated and neighboring rooms conducted 
pre-treatment application (pre-trial) and 1, 4, and 24 hours after treatment application* 
Room Test Pre-trial 1 hour 4 hours 24 hours
Treated ANOVA  F = 0.08,  P = 0.924  F = 214.50,  P < 0.001  F = 421.46,  P < 0.001  F = 29.54,  P < 0.001
LSD Control a coil a 
metofluthrin a 
Control a coil b 
metofluthrin b 
Control a coil b 
metofluthrin b 
Control a coil a 
metofluthrin b 
Neighboring ANOVA  F = 0.30,  P = 0.746  F = 29.49,  P < 0.001  F = 38.00,  P < 0.001  F = 50.23,  P < 0.001
LSD Control a coil a 
metofluthrin a 
Control a coil a 
metofluthrin b 
Control a coil b 
metofluthrin c 
Control a coil a 
metofluthrin b 
 *  ANOVA = analysis of variance; LSD = least significant difference. 
 a,b,c  Represent post hoc LSD grouping. Treatments with the same letter did not differ significantly. 
 Figure 2.  Mean mosquito landing counts (±SE) for both the 
treated and neighboring rooms conducted pre-trial and 1, 4, and 
24 hours post-treatment. 
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untreated neighboring room, 20/23 (87%) dead mosquitoes 
were found in the harborage areas, with only 2 and 1 found near 
the window and door, respectively. These proportions were 
not significantly different (χ 2 = 0.85,  P = 0.66) between treated 
and untreated rooms. Not surprisingly, a high proportion of 
mosquitoes released in the metofluthrin-treated room died; 
however, the spillover of metofluthrin into the neighboring 
room also resulted in high mortality of mosquitoes released 
in that room ( Figure 7 ). Mortality was significantly higher 
for metofluthrin treatment than the other treatments for 
mosquitoes released in the treated ( F = 108.77,  P < 0.001) and 
untreated neighboring room ( F = 47.19,  P < 0.001). 
 DISCUSSION 
 Throughout tropical regions of the world and Australia, den-
gue outbreaks are contained using mosquito control programs 
designed to reduce  Ae. aegypti populations, thereby dimin-
ishing mosquito biting and the risk of dengue transmission. 20 
Although this approach may be effective in limiting dengue 
transmission, there remains, albeit reduced, the potential for 
viremic cases and their nearest neighbors to be bitten by mos-
quitoes remaining in the area after control measures. 
 The metofluthrin-impregnated tower has great potential to 
further improve dengue control programs, as our study has 
shown it to be effective in reducing mosquito biting in a typical 
domestic setting. Previously, in laboratory studies, Lucas and 
others 9 found metofluthrin-impregnated paper strips reduced 
 Ae. aegypti human landings by 91.2%, and further, Lucas 
and others 8 found metofluthrin significantly reduced human 
landings by  Aedes spp. in the field. It is suspected that meto-
fluthrin causes a reduction in human biting through two main 
modes of pyrethroid action, first as a result of its knockdown 
activity and second because of the disruption in orientation 
toward the host. 15 In our study we showed that both the coil 
and, particularly, the metofluthrin emanator, reduced biting by 
 Ae. aegypti while the products were active and, with the meto-
fluthrin treatment, there was a strong spillover effect that sig-
nificantly reduced biting in the adjacent untreated room. 
 We also found metofluthrin to be highly lethal to  Ae. aegypti 
in the confined space of an apartment. The lethality of meto-
fluthrin had been demonstrated by Kawada and others 16 in the 
laboratory, where it caused 100% mortality of caged  Anopheles 
balabacensis when exposed at a distance of 2.4 meters over 
a 24-hour period. In the field, however, Kawada and others 15 
found no significant differences in the ages, determined by 
parity, of  Ae. aegypti collected between metofluthrin-treated 
and untreated houses and concluded that metofluthrin did not 
have a great impact on mosquito survival. 
 From aspirator collections in metofluthrin-treated and 
untreated shelters without walls 13,14 and houses, 15–17 Kawada 
and others reported that metofluthrin caused significant spa-
tial repellency. However, in our experiments, metofluthrin did 
not act as either a repellent or an expellant. Had metofluthrin 
been operating as a repellent, mosquitoes in the neighboring 
room would not have entered the room in which the meto-
 Figure 3.  Movement (mean ± SE) and fate of cohorts of 20 female 
 Ae. aegypti released in treated and untreated conjoined rooms. 
 Figure 4.  Mean (+SE) proportion of mosquitoes collected in the 
treated room for all mosquitoes collected after the 24-hour treatment 
exposure. Means with the same letter did not differ significantly (post-
hoc LSD grouping). 
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fluthrin tower had been activated; however, we did not use 
exit traps to measure mosquitoes exiting windows, and may 
have thus underestimated repellency by preventing mosquito 
escape via open windows. Conversely, our mosquitoes were 
more likely to be found, albeit dead, in the room containing 
the metofluthrin tower, and most dead mosquitoes were found 
on harborage objects in the treated room rather than at the 
window, which we hypothesized would be the case if they had 
been trying to exit. 
 Thus, our data suggests that mosquitoes released in the 
neighboring room entered the treated room searching for their 
first blood meal, whence they became disoriented, sought har-
borage, and were subsequently knocked down and killed by 
the metofluthrin action. Indeed, disoriented mosquitoes not 
attempting to land or bite on an exposed leg were observed 
flying in the treated room during the 1 hour post-treatment 
landing count. Furthermore, if metofluthrin was operating as 
expellant in the current study, then mosquitoes released into 
the metofluthrin-treated room would have exited that room. 
However, we found no difference in the number of mosqui-
toes leaving the metofluthrin-treated room compared with 
the untreated room. Some earlier field studies using metoflu-
thrin relied upon collection of adult mosquitoes in treated and 
untreated rooms using aspirators or glass vials, 13,15 and thus 
mosquitoes that were knocked down and killed may have been 
overlooked. Also, disoriented mosquitoes may have flown 
beyond the metofluthrin-affected air, then recovered and dis-
persed. It is also possible that mosquitoes were attracted by 
metofluthrin. 
 Knowledge of the behavior of female  Ae. aegypti exposed to 
metofluthrin is critical for the successful implementation of this 
control method. In particular, we must know whether female 
 Ae. aegypti exposed to metofluthrin either become disorien-
tated and are knocked down or rapidly exit the room through 
open windows and doors. If the latter, they would likely fly to 
nearby houses where they could potentially infect residents. 
Clearly, detailed observational studies quantifying the behav-
ioral response of  Ae. aegypti exposed to metofluthrin should 
be conducted under controlled field conditions to clarify this 
issue. Additionally, our studies were conducted at relatively 
cool temperatures (mean daily temperature in the low 20°C). 
This would have decreased biting activity and vaporization of 
metofluthrin. Further work should be conducted to determine 
the relationship of temperature to efficacy and longevity of 
the metofluthrin emanator. 
 There are interesting control implications raised by the pos-
sibility that metofluthrin can kill, but not repel mosquitoes. 
This suggests that, when paired with humans who would act 
as bait, metofluthrin could be the ultimate “Lure and Kill” 
trap. Multiple emanators of metofluthrin could be deployed 
 Figure 5.  Mean percentage of mosquitoes released ( N = 20) into 
the treated room and neighboring room that were lost, remained, or 
exited after 24-hour exposure to the metofluthrin, coil, and control 
treatments. 
 Figure 6.  Mean (+SE) proportion of dead mosquitoes for the 
household (pooled treatment and neighboring room) after 24-hour 
treatment exposure. The metofluthrin treatment was significantly 
 different from the coil and control by post-hoc LSD grouping. 
 Figure 7.  Mean cohort mortality (±SE) for the 20 mosquitoes 
released in either the treated (black bar) or neighboring (white bar) 
room after 24-hour treatment exposure. Post-hoc LSD groupings are 
given for the treated and neighboring rooms ( italics ). 
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within a household to minimize the risk of dengue transmis-
sion to residents. However, this strategy is not without risk, as 
attracted mosquitoes may still bite before being disorientated 
by the metofluthrin. Further studies should be conducted to 
determine how quickly metofluthrin stops biting activity in 
 Ae. aegypti attracted to a host. Nonetheless, area-wide deploy-
ment of metofluthrin emanators could be used to rapidly kill 
 Ae. aegypti and interrupt virus transmission in dengue foci. 
However, efforts to increase the duration that metofluthrin 
is released from emanators (labeled for 80 hours continuous 
use) should be made. Nevertheless, field trials using metoflu-
thrin over large contiguous areas are warranted. Registered 
metofluthrin emanators, in concert with biodegradable lethal 
ovitraps, 21 could be provided to the public as part of a “do it 
yourself” community participation dengue control strategy. If 
metofluthrin emanators were commercially available, media 
campaigns and websites (e.g.,  http://www.health.qld.gov.au/
dengue/default.asp ) encouraging their use during an outbreak 
could be effective. Echoing this point, Morrison and oth-
ers 22 highlighted the need to develop and test products that 
appeal to the consumer for the control of  Ae. aegypti . Finally, 
our study indicates that coils provide good repellency within 
a room while the coil is burning. However, they do not appear 
to kill mosquitoes and would be of limited value in breaking 
dengue transmission. 
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